EUCTR2006-000908-17-IT进行中（未招募）不适用
Medical therapy of keratoconus with Riboflavin/Ultraviolet-A collagen Cross-Linking and investigation of the corneal stromal and Keratocytes modifications apoptosis and stromal repopulation with confocal microscopy and topo-aberrometric link firstly in vivo. Validation of the previous results ex vivo in animal and human enucleated eyes in human patients affected from progressive keratoconus. - X Linking
AZIENDA OSPEDALIERA SENESE0 个研究点目标入组 200 人开始时间: 2006年4月21日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Male and female gender - Age 14-60 years - patients subscribing specific informed consent - progressive keratoconus and corneal ectasia clinically and topoaberrometrically documented - corneal thikness / 400 microns
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- patients affected by other corneal desease - corneal thikness 400 microns - patients affected by HSV keratitis
研究者
相似试验
Unknown
不适用
Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal EctasiaCorneal EctasiaNCT01123057Singapore National Eye Centre30
已完成
不适用
Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Corneal RingKeratoconusNCT00832897Federal University of São Paulo31
Unknown
2 期
UVA-Riboflavin Crosslinking Treatment of Corneal EctasiaEctasiaCorneal EctasiaKeratoconusNCT01325298Mercy Center for Corrective Eye Surgery250
已完成
不适用
Evaluation of efficacy and safety of riboflavin/UVA treatment for keratoconus/keratectasiaJPRN-UMIN000002947Department of Ophthalmology, Keio University School of Medicine30
招募中
不适用
ew surgical treatment for keratoconuscorneal ectatic disorderKeratoconus/surgeryH186JPRN-jRCTs052180171Kinoshita Shigeru500